Thynk Health Appoints Matt Rockhold as Chief Commercial Officer to Accelerate AI-Driven Cancer Detection Across U.S. Health Systems

LEXINGTON, Ky., Sept. 22, 2025 /PRNewswire/ — Thynk Health, a leading innovator in AI-powered diagnostic platforms, today announced the appointment of Matt Rockhold as Chief Commercial Officer. In this role, Rockhold will lead the company’s go-to-market strategy, customer growth initiatives, and commercial execution as Thynk Health scales its impact across the U.S. healthcare system.

An accomplished sales and commercial executive with over two decades of experience in medical technology and AI-enabled diagnostics, Rockhold brings a proven track record of driving revenue growth, launching breakthrough technologies, and forging strategic partnerships across integrated delivery networks (IDNs), radiology groups, and complex healthcare ecosystems.

At Thynk Health, Rockhold is responsible for accelerating adoption of the company’s category-defining platform for lung cancer screening and incidental findings management. The AI-powered solution transforms manual workflows into streamlined, automated, and compliant systems—helping providers catch more cancers earlier, improve follow-up adherence, and enhance operational efficiency.

“I’m excited to be a part of the Thynk team as we redefine how health systems manage lung cancer screening and incidental findings by combining AI, automation, and clinical insight into one seamless platform,” said Rockhold. “This is a great time to be at Thynk Health as we help accelerate earlier cancer diagnoses, improve patient outcomes, and empower providers with the tools they need to close critical follow-up gaps.”

Rockhold’s leadership is grounded in execution, accountability, and mission alignment. He is deeply passionate about closing the follow-up gap in cancer detection and helping health systems move from fragmented data to life-saving action.

Prior to joining Thynk Health, Rockhold has held commercial leadership roles at both large medical device and imaging technology companies, as well as AI software ventures breaking into the U.S. Markets, where he consistently exceeded performance targets and scaled multi-million-dollar business units.

About
Thynk Health delivers the industry’s leading AI-powered platform for managing cancer screening and incidental findings across all major organ systems. Our comprehensive suite of solutions spans Pulmonary, Cardiovascular, Digestive, Liver, Endocrine, GU, and Women’s Health, as well as ER Tracking—empowering health systems to proactively identify at-risk patients, automate communications, streamline workflows, and ensure timely follow-up. Thynk Health integrates seamlessly with any EHR and existing hospital systems (EHR, DICOM, PACS, scheduling, and more), providing actionable analytics and enterprise-wide visibility that improve outcomes, enhance operational efficiency, and reduce liability. Learn more at thynkhealth.com

Contact 
Thynk Health
1-855-633-6963
info@thynkhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/thynk-health-appoints-matt-rockhold-as-chief-commercial-officer-to-accelerate-ai-driven-cancer-detection-across-us-health-systems-302562303.html

SOURCE Thynk Health